MLANA and melanoma: Conjugation of liposomes with Leb and Lea for DC-SIGN targeting enhances both binding and DC-SIGN-mediated internalization of these liposomes by bone marrow-derived DCs (BMDCs) and have also shown efficient CD4+ and CD8+ T lymphocyte responses against melanoma antigen, MART-1 [158].